Standard Contracts
●] Shares MAXCYTE, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • July 26th, 2021 • Maxcyte, Inc. • Services-commercial physical & biological research • New York
INDEMNIFICATION AGREEMENTIndemnification Agreement • July 26th, 2021 • Maxcyte, Inc. • Services-commercial physical & biological research • Delaware
This Indemnification Agreement (this “Agreement”) dated as of July ___, 2021, is made by and between MaxCyte, Inc., a Delaware corporation (the “Company”), and _________________ (“Indemnitee”).
SEVERANCE AGREEMENTSeverance Agreement • January 26th, 2024 • Maxcyte, Inc. • Services-commercial physical & biological research • Maryland
THIS SEVERANCE AGREEMENT is made as of March 10, 2023 (the “Effective Date”), by and between MaxCyte, Inc., a Delaware corporation (the "Company"), and Cenk Sumen (the "Executive").
DEED OF LEASELease Agreement • March 15th, 2023 • Maxcyte, Inc. • Services-commercial physical & biological research
This Lease (the “Lease”) is made this ____ day of ___________, 2021 (the “Effective Date”), between KEY WEST MD OWNER LLC, a Delaware limited liability company (“Landlord”), and MAXCYTE, INC., a Delaware corporation (“Tenant”).
MAXCYTE, INC. LONG-TERM INCENTIVE PLAN NON-STATUTORY STOCK OPTION AGREEMENT FOR US PERSONSNon-Statutory Stock Option Agreement • June 25th, 2021 • Maxcyte, Inc. • Services-commercial physical & biological research
SEVERANCE AGREEMENTSeverance Agreement • March 15th, 2023 • Maxcyte, Inc. • Services-commercial physical & biological research • Maryland
THIS SEVERANCE AGREEMENT is made as of March 8, 2017 (the "Effective Date"), by and between MaxCyte, Inc., a Delaware corporation (the "Company"), and Ronald E. Holtz (the "Executive").
Gaithersburg, MD 20878Separation Agreement • August 10th, 2022 • Maxcyte, Inc. • Services-commercial physical & biological research • Illinois
EIGHTH AMENDMENT TO LEASE AGREEMENTLease Agreement • June 25th, 2021 • Maxcyte, Inc. • Services-commercial physical & biological research
THIS EIGHTH AMENDMENT TO LEASE AGREEMENT (“this Eighth Amendment”) is made as of September 27, 2019 (“Eighth Amendment Effective Date”), by and between ARE-20/22/1300 FIRSTFIELD QUINCE ORCHARD, LLC, a Delaware limited liability company, having an address at 385 E Colorado Boulevard, Suite 299, Pasadena, California 91101 (“Landlord”), and MAXCYTE, INC., a Delaware corporation, having an address at 22 Firstfield Road, Suite 110, Gaithersburg, Maryland 20878 (“Tenant”).
AMENDMENT TO DEED OF LEASEDeed of Lease • March 15th, 2023 • Maxcyte, Inc. • Services-commercial physical & biological research
THIS AMENDMENT TO DEED OF LEASE (this “Amendment”) is made this ____ day of ____________________, 2021 (the “Effective Date”), by and between key west md owner llc, a Delaware limited liability company (“Landlord”), and MAXCYTE, INC., a Delaware corporation (“Tenant”).
FIRST AMENDMENT TO SUBLEASESublease • June 25th, 2021 • Maxcyte, Inc. • Services-commercial physical & biological research
This First Amendment to Sublease (“First Amendment”) is entered into as of the 9th day of September, 2019, by and between NOVAVAX, INC., a Delaware corporation (“Sublandlord”), and MAXCYTE, INC., a Delaware corporation (“Subtenant”).
FIRST AMENDMENT TO SUBLEASESublease • June 25th, 2021 • Maxcyte, Inc. • Services-commercial physical & biological research
This First Amendment to Sublease (“First Amendment”) is entered into as of the 9th day of September, 2019, by and between NOVAVAX, INC., a Delaware corporation (“Sublandlord”), and MAXCYTE, INC., a Delaware corporation (“Subtenant”).
SUBLEASESublease • June 25th, 2021 • Maxcyte, Inc. • Services-commercial physical & biological research
This Sublease (“Sublease”) is made as of the 9th day of September, 2019 (the “Effective Date”), by and between Novavax, Inc., a Delaware corporation (“Sublandlord”), and MaxCyte, Inc., a Delaware corporation (“Subtenant”).
AMENDMENT TO DEED OF LEASEDeed of Lease • March 22nd, 2022 • Maxcyte, Inc. • Services-commercial physical & biological research
THIS AMENDMENT TO DEED OF LEASE (this “Amendment”) is made this ____ day of ____________________, 2021 (the “Effective Date”), by and between key west md owner llc, a Delaware limited liability company (“Landlord”), and MAXCYTE, INC., a Delaware corporation (“Tenant”).
CONSULTING AGREEMENTConsulting Agreement • August 10th, 2022 • Maxcyte, Inc. • Services-commercial physical & biological research • Illinois
This Consulting Agreement (the “Agreement”) by and between MaxCyte, Inc. (“Client”) and Amanda Murphy, an individual (“Consultant”) is effective as of April 15, 2022 (the “Effective Date”).
ContractTransition Agreement • March 12th, 2024 • Maxcyte, Inc. • Services-commercial physical & biological research • Maryland
ContractSeverance Agreement • March 12th, 2024 • Maxcyte, Inc. • Services-commercial physical & biological research
